Descriptor English: | Imipenem | ||||||
Descriptor Spanish: |
Imipenem
| ||||||
Descriptor Portuguese: | Imipenem | ||||||
Descriptor French: | Imipénem | ||||||
Entry term(s): |
Anhydrous Imipenem Anhydrous, Imipenem Imipemide Imipenem Anhydrous Imipenem, Anhydrous MK 0787 MK-0787 MK0787 N Formimidoylthienamycin N-Formimidoylthienamycin |
||||||
Tree number(s): |
D02.065.589.099.124.300.500 D03.633.100.300.124.300.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015378 | ||||||
Scope note: | Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents |
||||||
Registry Number: | 71OTZ9ZE0A | ||||||
CAS Type 1 Name: | 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))- | ||||||
Previous Indexing: |
Antibiotics (1980-1982) Thienamycins (1983-1988) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 28157 | ||||||
Unique ID: | D015378 | ||||||
NLM Classification: | QV 350 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/06/03 | ||||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Imipenem
- Preferred
Imipenem, Anhydrous
- Narrower
MK-0787
- Narrower
Concept UI |
M0023689 |
Scope note | Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. |
Preferred term | Imipenem |
Entry term(s) |
Imipemide N Formimidoylthienamycin N-Formimidoylthienamycin |
Concept UI |
M0329530 |
Preferred term | Imipenem, Anhydrous |
Entry term(s) |
Anhydrous Imipenem Anhydrous, Imipenem Imipenem Anhydrous |
Concept UI |
M0351093 |
Preferred term | MK-0787 |
Entry term(s) |
MK 0787 MK0787 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey